Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
A Phase 1/2 Study of Alefacept, a CD2 Receptor Antagonist in Patients With Relapsed/Refractory Aplastic Anemia A Phase 1/2 Study of Alefacept, a CD2 Receptor Antagonist in Patients With Relapsed/Refractory Aplas ...
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation for Children With Non-Malignant Diseases Who Have Been Multiply Transfused: a Pilot Study Alefaceptand Allogeneic Hematopoietic Stem Cell Transplantation for Children With Non-Malignant Dise ...